Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease

scientific article published on 06 April 2012

Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JFO.2011.07.017
P698PubMed publication ID22483761

P2093author name stringC Baudouin
A Bron
V Baeyens
Vismed/Hylovis Study Group
P433issue6
P921main subjecteye diseaseQ3041498
P304page(s)412-419
P577publication date2012-04-06
P1433published inJournal Francais d'OphtalmologieQ15749105
P1476titleEfficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease
P478volume35

Reverse relations

cites work (P2860)
Q34474379A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome
Q33553643Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
Q35507058Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial
Q92354005Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery
Q36362131Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model
Q41817907Investigating the potential benefits of a new artificial tear formulation combining two polymers
Q35690598Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.
Q24186110Over the counter (OTC) artificial tear drops for dry eye syndrome
Q41489266Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis
Q33800691Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia

Search more.